Carving Out New Spaces In Cancer Immunotherapy

An Interview With iTeos Therapeutics co-founder, president and CEO Michel Detheux

 
• By Ben Comer
  
Cambridge, MA skyline
The move to Cambridge helped iTeos transition into the company it is today, said Detheux
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Leadership

More from In Vivo